Lunit Cancer Screening’s Post

From the vibrant discussions at #TheEuropeanCongressofRadiology (ECR 2024) in Vienna, we MATICAL INNOVATION are eager to highlight our key takeaways and express our heartfelt thanks to all who made this event possible. The congress once again proved radiology's critical role at the forefront of #healthcare innovation, with a keen focus on #artificialintelligence (AI) for #cancerimaging. We and our partners participated in the key sessions dedicated to AI for Health Imaging projects #AI4HI, showcasing the synergies and progress of projects like #CHAIMELEON, #EuCanImage, #INCISIVE, and #ProCancer-I; and the European Cancer Image Infrastructure #EUCAIM, led by Dr. Luis Marti-Bonmati. The insights shared by our CEO, Mario Aznar, about EUCAIM's mission and its significance within the EU's health data space and the AI industry landscape towards personalized medicine underscored the initiative's potential to accelerate oncology research and innovation across Europe. As we look forward, inspired by the achievements and potential collaborations, we remain committed to advancing healthcare through innovation. Join us in this journey towards a healthier, stronger Europe, where technology and human endeavor meet to create a brighter tomorrow. For more insights into EUCAIM and the Cancer Image Europe platform, including a short informative video, visit: https://bit.ly/EUCAIM #ECR2024 #Radiology #AIinHealthcare #EUCAIM #CancerImaging #HealthcareInnovation #EIBIR #matical

Just how trusted is Transpara? Let's break it down 🗂: Capacity constraints are a major problem in Europe, leading to burnout (including depersonalization) among radiologists. So we introduced Transpara. Across multiple European regions, Transpara is the trusted #BreastAI to replace a reader in mammography screening - and supports radiologists reading. 🔍Transpara is now in use in nearly every major western European country 🔍In Denmark, Spain, and Sweden, Transpara is used both to support reading and replace the second reader, based on a woman's risk 🔍The world's first and only Randomized Controlled Trial in Sweden (MASAI) drove a change in the standard of care! How was this achieved? Through rigorous, evidence-backed validation, all available for your review in our clinical summaries from our website bit.ly/3ysYi4I #Transpara is tried, tested, and trusted. We take clinical evidence seriously, proving it through the most rigorous methods. #HealthAI #ClinicalResearch Lauritzen, et al, Radiology, 2024 Raya-Povedano, et al, Radiology, 2021 Lång, et al, Lancet Oncology, 2023

#GoodNewsFriday continues – here’s another exciting update from our members! contextflow, a member of the Cardiovascular Therapies market group, has secured Europe’s first radiology AI reimbursement contract with IKK Südwest! This agreement is set to transform lung cancer detection and pave the way for broader AI adoption in medical imaging across Europe. contextflow’s advanced AI-powered software helps radiologists detect lung cancer up to a year earlier with remarkable accuracy. This innovation not only enhances diagnostic capabilities but also reduces unnecessary procedures, leading to better outcomes for patients and cost efficiencies for healthcare providers. Congratulations to the contextflow team on this achievement! 🚀 Read more – link in the comments. Yours, EurA AG, Hello Tomorrow, Tech Tour, EuroQuity - Bpifrance, IESE Business School, Webrazzi / Tech.eu and the European Innovation Council and SMEs Executive Agency (EISMEA) Gilles Le Cocguen; Nassima Ferahtia; William Stevens; Teresa Cunha; Nicolette Komitska; Denitsa Nenkova; Yasemin Baran; Iva Tchetinova; Ricardo Greenfield; Valentin Marin; Etienne Pebrier; Josemaria Siota; Alberto Garcia Picazo; Alizée Blanchin; Lucas MAURICE; Carmo Cupertino de Miranda; Oriana B.; Cristiana Gonçalves; Rute Mata João; Joana Bragança; Márcia Macieira; Jan Bernlöhr; Marc Ranchon; Irmak Acar; Julia Gifford #EICScalingClub #CardiovascularTherapies #contextflow #EUinnovation

NEW VJSessions 💬 🩸 In this exclusive session, leading experts Daniel Lenihan, Raúl Córdoba Mascuñano, and Iskra Pusic discuss the importance of #cardiooncology, awareness around the #ESC 2022 cardio-oncology guidelines, and the value of building a #multidisciplinary team 🔦 🫀 The experts share insights into the efforts of global societies to implement the ESC guidelines into #clinical practice, strategies to prevent #cardiactoxicities in patients being treated for #hematologicmalignancies, and the essential collaboration of #hematologists and #cardiologists Take a look 👉 https://lnkd.in/egvnPfsx #VJHemOnc

Which #meningioma patients will benefit from #radiation? This study, co-authored by Stephen Magill, MD, PhD and done in collaboration with University of California, San Francisco, discovered a #biomarker which has the potential to guide treatment plans for 30% of this #BrainTumor patient population. In this video, Dr. Magill and radiation #oncologist Tarita Thomas, MD, PhD, explain the impact of these findings. You can learn more about this #study by clicking here: https://lnkd.in/dgmm5YnF. #BTAM #BrainTumorAwarenessMonth #Education #PatientEd #PatientEducation #BrainTumorPatient #Breakthrough #Biomarkers #BTSM #RadiationTherapy

You recently discovered The CHAIMELEON Project and you´re feeling out of the loop? No worries! We've got the perfect video to keep you in the know and up-to-date 😉 Luis Marti-Bonmati captivated the audience with his insightful talk at the European Congress of Radiology 2024 on how CHAIMELEON is reshaping medical imaging research! 💫 At #ECR2024, Prof. Luis Martin-Bonmati highlighted how CHAIMELEON is revolutionizing the field by implementing #harmonization processes that streamline resource #integration and research #facilitation 🔁 The #OpenChallenges introduced by CHAIMELEON empowered researchers to rigorously test model #reproducibility and #accuracy, ensuring more reliable results in medical imaging 🔬 Moreover, CHAIMELEON's #sustainability efforts are bolstering the European Federation for European Federation for Cancer Images (EUCAIM) by enhancing data sharing, tool accessibility, and fostering a robust research community 🤝 Curious to learn more about our initiatives or keen on joining our collaborative efforts? Visit our website or reach out to us today! 🌐📩 https://chaimeleon.eu/ #H2020 #EUfunded #CancerResearch #Innovation #ECR2024

RSNA is always a lot of fun. Fun in the sense that you get to meet a lot of great people who are just awesome to be around. Fun in the sense that you get to learn a lot of new things and have many interesting and important conversations. Fun in the sense that you walk away inspired to continue your everyday work. For me, this means returning home to Sectra in Sweden with a wealth of input and ideas on how we can continue our work with Amplifier Services, with the aim of helping healthcare providers adopt AI for clinical use. #RSNA2024 #SECTRA #AI #RADIOLOGY

Our work, titled "𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗰 𝗖𝗹𝗮𝘀𝘀𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗣𝗿𝗲𝗺𝗮𝗹𝗶𝗴𝗻𝗮𝗻𝘁 𝗖𝗲𝗿𝘃𝗶𝗰𝗮𝗹 𝗟𝗲𝘀𝗶𝗼𝗻𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗖𝗼𝗹𝗽𝗼𝘀𝗰𝗼𝗽𝗶𝗰 (𝗩𝗜𝗔) 𝗜𝗺𝗮𝗴𝗲𝘀 𝗨𝘀𝗶𝗻𝗴 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲," has been featured in 𝗙𝗿𝗼𝗻𝘁𝗶𝗲𝗿𝘀 𝗶𝗻 𝗢𝗽𝘁𝗶𝗰𝘀 𝟮𝟬𝟮𝟰. The project aims to bridge between Optics, AI and Medical Diagnosis to provide low-cost solution to early diagnosis of cervical cancer, especially in rural India, where access to advanced diagnostic facilities remains a significant challenge. This achievement wouldn’t have been possible without the unwavering guidance and mentorship of Dr. Uttam Pal, Dr. Arpitha Anantharaju, and Dr. Rohini P. Grateful to contribute with an amazing team: Humaira Firdowse, Sakthiprian S, Karthikeyan S, Keerthana A, Kala N, Sukanya S, Kaarthiga R G and Murli S. The session took place on Sept 23-26 2024, at Colorado Convention Centre, Denver, as part of Annual Optics Conference of OPTICA Group. This was a fantastic opportunity to exchange ideas and contribute to advancements in healthcare and technology. #AI #Healthcare #CervicalCancer #FiOLS2024 #Optics #ArtificialIntelligence Link: https://lnkd.in/gfgHKSjU

✨ It is always a privilege to collaborate with outstanding investigators, and presenting new findings from the ALTiIMETER trial at European Society of Retina Specialists (EURETINA) was no exception. Our deep dive into the 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 of DME treatment, focusing on morphological changes and cytokine profiles, has truly expanded my understanding of how treatment can modulate key mechanisms behind 𝐦𝐚𝐜𝐮𝐥𝐚𝐫 𝐥𝐞𝐚𝐤𝐚𝐠𝐞. Working alongside international experts continues to be an enriching experience, with every exchange leading to new perspectives and deeper insights into patient care. Grateful for such effective DME therapies that help so many patients! What are your thoughts on the role of 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 in shaping the future of DME treatment? 📄 Do we need to pay attention to a different = correct parameter at each stage of DR? 🤔 Thanks to the whole team Manuel Amador, MD Andreas Dieckmann, Kara Gibson PhD, Carl Glittenberg, Alex K., Florie Mar, PhD, Audrey Souverain, Björn Titz, Stela Vujosevic, Amani Fawzi #Ophthalmology #EURETINA #DME #Biomarkers #Collaboration #PatientCare #TreatDR #DryDME

Our innovations are not only groundbreaking, but stay true to solving the unmet needs on the ground. This year at #SHBC2024, we are proud to have showcased our healthcare innovations at the Research and Innovation @NHG Exhibition, where we had the privilege of hosting Minister Ong Ye Kung to witness our advancements firsthand. The first of 3 projects highlighted was project PRIME CXR. It integrates an AI-powered chest X-ray (CXR) analysis solution, Lunit INSIGHT CXR, into our diagnostic radiology systems for use in primary care. This is a collaborative effort led by Tan Tock Seng Hospital's and National Healthcare Group Polyclinics’s radiologists Cher Heng Tan, Alvin Soon 孙涌泉 and primary care physician Qi Wei Fong. The innovative triage tool serves to prioritise urgent abnormal CXRs for review and has the potential to reduce patient wait times to early intervention or discharge. Thankful for the partnership with Lunit Cancer Screening and Resaro; as well as the support of Synapxe for the onboarding of Lunit INSIGHT CXR onto the AI Medical Imaging for SG Public Healthcare Platform #AIMSG. We appreciate the National Health Innovation Centre (NHIC)’s belief in and support for this transformative effort. Kyung-sik Jo Karen Gill Rohan Lal Jin Park Timothy Lin Miguel Fernandes National Healthcare Group #HealthcareInnovation #Clinicaladoption #AIinHealthcare #innovators #partnership #artificialintelligence #chestxray #diagnostics